October 12, 2016 – Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (“CVR Medical”) is pleased to announce that it has entered into an agreement with Venture Liquidity Providers Inc. (“VLP”), subject to regulatory approval, to provide assistance in maintaining an orderly trading market for the common shares of the Company (the “Services”).
The market-making service will be undertaken by VLP through a registered broker, W.D. Latimer Co. Ltd., in compliance with the applicable policies of the TSX Venture Exchange and other applicable laws. For its services, CVR Medical has agreed to pay $5,000 CAD per month for a period of 12 months to VLP. The agreement may be terminated at any time by either CVR Medical or VLP. CVR Medical and VLP act at arm’s length, and VLP has no present interest, directly or indirectly, in CVR Medical or its securities. The finances and the shares required for the market-making service are provided by W.D. Latimer. The fee paid by CVR Medical to VLP is for only the Services.
VLP is a specialized consulting firm based in Toronto, Ontario providing a variety of services focused on TSX-V-listed issuers.
About CVR Medical
CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.